Maria Stella Franzè

13PUBLICATIONS
39CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursMedical biochemistry - lipidsCardiology (incl. cardiovascular diseases)Medical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Aug 08, 2026
Dual TIGIT and PD-1 blockade in immunotherapy-refractory hepatocellular carcinoma: a signal beyond resistance?

|Apr 18, 2026
From Cure to Complexity: Post-SVR Liver and Metabolic Trajectories in Diabetic Patients.

|Mar 12, 2026
Trabecular bone score enhances fracture risk stratification in patients with metabolic dysfunction-associated steatotic liver disease and type 2 diabetes mellitus.

Clelia Asero, Cecilia Oliveri, Maria Stella Franzè

|Feb 10, 2026
Indeterminate Phase/Grey Zone of Chronic Hepatitis B: Clinical Features, Outcomes and Molecular Insights.

Maria Stella Franzè, Teresa Pollicino, Jean-Michel Pawlotsky

|Sep 13, 2025
MASLD Under the Microscope: How microRNAs and Microbiota Shape Hepatic Metabolic Disease Progression.

Clelia Asero, Maria Stella Franzè, Irene Cacciola

|Dec 13, 2024
Selective internal radiation therapy across Barcelona Clinic Liver Cancer (BCLC) stages of hepatocellular carcinoma: literature review.

Paul Vigneron, Maria Stella Franzè, Julia Chalaye

Pageof 3

Frequent Collaborators

5 joint publications

Irene Cacciola

4 joint publications

Giovanni Squadrito

4 joint publications

Giovanni Raimondo

2 joint publications

Roberto Filomia